Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

2 ArticlesPharma Stocks

1 / 1

Outlier in Focus – Divi's Laboratories.

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. See a video of how Outliers ...
Outlier-in-Focus.png

FDA's New Rules Propels Generic and Biosimilar Approvals

Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...
Original-Abbreviated-New-Drug-Application-ANDA-Approvals-10-November-2016.png